Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for GERN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 94.94%
March 31, 2026 96.74%
December 31, 2025 97.28%
September 30, 2025 97.13%
June 30, 2025 96.94%
March 31, 2025 96.18%
December 31, 2024 98.35%
September 30, 2024 97.68%
June 30, 2024 49.43%
March 31, 2024 9.54%
December 31, 2023 -947.8%
September 30, 2023 0.00%
June 30, 2023 -848.3%
March 31, 2023 -1.10K%
December 31, 2022 -122.3%
September 30, 2022 0.00%
June 30, 2022 -195.9%
March 31, 2022 -60.98%
December 31, 2021 78.27%
September 30, 2021 0.00%
June 30, 2021 0.00%
March 31, 2021 0.00%
December 31, 2020 0.00%
September 30, 2020 0.00%
June 30, 2020 0.00%
Date Value
March 31, 2020 0.00%
December 31, 2019 0.00%
September 30, 2019 0.00%
June 30, 2019 0.00%
March 31, 2019 73.68%
December 31, 2018 0.00%
September 30, 2018 0.00%
June 30, 2018 0.00%
March 31, 2018 0.00%
December 31, 2017 0.00%
September 30, 2017 0.00%
June 30, 2017 0.00%
March 31, 2017 0.00%
December 31, 2016 0.00%
September 30, 2016 0.00%
June 30, 2016 0.00%
March 31, 2016 0.00%
December 31, 2015 0.00%
September 30, 2015 0.00%
June 30, 2015 0.00%
March 31, 2015 0.00%
December 31, 2014 0.00%
September 30, 2014 0.00%
June 30, 2014 0.00%
March 31, 2014 0.00%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Precigen, Inc. 94.32%
Editas Medicine, Inc. 96.50%
Agenus, Inc. 98.50%
Amgen, Inc. 72.08%
Anika Therapeutics, Inc. 65.15%

Gross Profit Margin (Quarterly) Related Metrics